PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
09-Oct-2025 Terumo Blood and Cell Technologies and Hemex Health join forces to improve outcomes for millions with sickle cell disease and other hemoglobin disorders Terumo BCT, Hemex Health
09-Oct-2025 Uniphar On Track to Achieve SBTi Target of Halving Scope 1 and 2 Emissions by 2030 Uniphar
09-Oct-2025 Glen Clova Scientific Announces Clinical Advisory Board for its Immuno-Dermatology Pipeline Glen Clova Scientific
08-Oct-2025 ANGLE plc - Appointment of Executive Chairman, proposed change of name and strategy update ANGLE plc
08-Oct-2025 AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors Sanofi
08-Oct-2025 Macomics Announces Neurodegeneration and Neuroinflammation Applications of ENIGMAC Drug Discovery Platform Macomics
07-Oct-2025 Hikma and Celltrion strengthen partnership to expand biosimilar access in MENA Hikma
07-Oct-2025 Onco3R Therapeutics Announces Completion of First Cohort in Phase 1 Trial of Novel SIK3 inhibitor O3R-5671 and Oral Presentation at UEGW 2025 Onco3R Therapeutics
07-Oct-2025 Medicines Discovery Catapult Announced as Newest Innovate UK Knowledge Base, Supporting Life Science Sector Growth Medicines Discovery Catapult
07-Oct-2025 Resolution Therapeutics to present EMERALD study design at the British Association for the Study of the Liver (BASL) annual meeting 2025 Resolution Therapeutics
02-Oct-2025 Neuraxpharm strengthens multiple sclerosis portfolio with the launch of Riulvy® (tegomil fumarate) Neuraxpharm
02-Oct-2025 Neuraxpharm strengthens multiple sclerosis portfolio with the launch of Riulvy® (tegomil fumarate) Neuraxpharm Group
02-Oct-2025 Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged 4 to 11 years Pharming Group
02-Oct-2025 Igyxos Biotherapeutics Awarded EUR 5.7 Million from the French Government to Accelerate Development of its First-in-class Monoclonal Antibody for the Treatment of Infertility Igyxos Biotherapeutics
02-Oct-2025 Ciloa Andrew Lloyd Associates
01-Oct-2025 e-therapeutics Relaunches as Tangram Therapeutics and Unveils LLibra OS e-therapeutics
01-Oct-2025 Elemental Machines Recognized in New Gartner® Hype Cycleâ„¢ for the Internet of Things, 2025 Report Elemental Machines
01-Oct-2025 Phastar Scoops Multiple Finalist Positions in 2025 SCRIP Awards Phastar
01-Oct-2025 Spin-out raises £2m for new gene-editing tool Forge Genetics
01-Oct-2025 Tessellate Bio Appoints Katie Chapman as Chief Scientific Officer Tessellate Bio